Search

Wednesday 26 June 2024

Memphasys (ASX: MEM): Accelerates FelixTM System

Reproductive biotechnology company Memphasys (ASX: MEM) has accelerated its FelixTM System sales orders in Japan, under its exclusive agreement with Vitrolife Japan KK, to sell and distribute the FelixTM System | ASX announcement: https://announcements.asx.com.au/asxpdf/20240318/pdf/061lr49l0r8k8h.pdf

Free stock updates

Subscribe to receive the latest stock news, CEO interviews, expert insights, events and offers directly into your inbox